Silverback Asset Management »

Esperion Therapeutics shares owned by Silverback Asset Management

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Silverback Asset Management from 13F filings

Historical chart of Silverback Asset Management investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Silverback Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Silverback Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $198M 100k 1976.72
2023-06-30 $280M 100k 2803.71
2023-03-31 $321k 100k 3.21

More positions owned by Silverback Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Cyberark Software Note 11/1 (Principal)
Dish Network Corporation Note 3.375% 8/1 (Principal)
Fubotv Note 3.250% 2/1 (Principal)
Infinera Corp Note 3.750% 8/0 (Principal)
Nova Note 10/1 (Principal)
Ivanhoe Mines Note 2.500% 04/15/26 (Principal)
Lumentum Hldgs Note 0.500%12/1 (Principal)
Varonis Sys Note 1.250% 8/1 (Principal)
Wayfair Note 1.000% 8/1 (Principal)
Digitalocean Hldgs Note 12/0 (Principal)
Liveperson Note 12/1 (Principal)
Bandwidth Note 0.250% 3/0 (Principal)
Infinera Corp Note 2.500% 3/0 (Principal)
Ford Mtr Co Del Note 3/1 (Principal)

View all positions for Silverback Asset Management

Top funds holding Esperion Therapeutics

Daniel D. Thurber
Vanguard Group
Bellevue Group
Meditor
Millennium Management
Two Sigma Investments
Two Sigma Advisers
Jpmorgan Chase & Co
Tang Capital Management
D. E. Shaw & Co
Walleye Trading
GSA Capital Partners
Schonfeld Strategic Advisors
Jacobs Levy Equity Management
Goldman Sachs Group

View all funds holding Esperion Therapeutics